explore -WSS

explore

author：Wikipedia 2025-09-28 10:20:16 - browse：6

Three Wegovy injection pens in a row — first opinion coverage from STAT — Adobe

Novo Nordisk will test whether its GLP-1 drugs can help people with alcohol-associated liver disease, and, as part of that, will study if the treatments will change the amount of alcohol people drink.

This appears to be the first time the company is getting involved in research to see if the booming class of GLP-1 diabetes and obesity drugs can affect substance consumption, a question that academic researchers have been probing but the pharmaceutical industry has so far avoided.

The nine-month study will try three drugs alone and in combinations against placebo. The primary outcome being tested is change in liver scarring, or fibrosis, and one of the secondary outcomes is changes in alcohol consumption. The news of the study was first reported by Bloomberg.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Supreme Court strikes down Biden student loan forgiveness program

entertainment

WSS

The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches

AI can’t replace a physician’s gut feeling

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

FDA approves RSV monoclonal antibody for infants, toddlers

Group opposing PBM reform sets lobbying record

Anger, defiance, fear over Supreme Court decision to block student loan forgiveness

entertainment

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+.

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

New lesbian bars spark hope amid disappearing LGBTQ+ spaces

Medical records are filled with copy

ADA: All diabetes patients should be screened for liver condition

Cancer drug shortages should be causing more outrage

ADA: All diabetes patients should be screened for liver condition

Tori Bowie and the unacceptable rates of Black maternal death

New lesbian bars spark hope amid disappearing LGBTQ+ spaces

Alkermes shareholders re

Prince Harry seeks over $550,000 in phone hacking lawsuit against British tabloid publisher

knowledge

Why hospitals are withdrawing from US News rankings

UnitedHealth wins $3.3 billion takeover of Amedisys

The strange history of BMI, the body mass index

Sanders adds drug shortage policies to pandemic preparedness bill

Federal board approves $12.7 billion budget for Puerto Rico as island shakes off bankruptcy

STAT Virtual Event: The State of Biosimilars: What to Watch

entertainment

hotspot

Wikipedia

hotspot